<!DOCTYPE article PUBLIC "-//NLM//DTD Journal Archiving and Interchange DTD v2.1 20050630//EN" "archivearticle.dtd"><article xmlns:xlink="http://www.w3.org/1999/xlink" article-type="research-article"><front><journal-meta><journal-id journal-id-type="nlm-ta">Genome Biol</journal-id><journal-title>Genome Biology</journal-title><issn pub-type="ppub">1465-6906</issn><issn pub-type="epub">1465-6914</issn><publisher><publisher-name>BioMed Central</publisher-name><publisher-loc>London</publisher-loc></publisher></journal-meta><article-meta><article-id pub-id-type="publisher-id">gb-2005-6-13-246</article-id><article-id pub-id-type="pmid">16420676</article-id><article-id pub-id-type="doi">10.1186/gb-2005-6-13-246</article-id><article-categories><subj-group subj-group-type="heading"><subject>Protein Family Review</subject></subj-group></article-categories><title-group><article-title>The AP-2 family of transcription factors</article-title></title-group><contrib-group><contrib id="A1" contrib-type="author"><name><surname>Eckert</surname><given-names>Dawid</given-names></name><xref ref-type="aff" rid="I1">1</xref></contrib><contrib id="A2" contrib-type="author"><name><surname>Buhl</surname><given-names>Sandra</given-names></name><xref ref-type="aff" rid="I1">1</xref></contrib><contrib id="A3" contrib-type="author"><name><surname>Weber</surname><given-names>Susanne</given-names></name><xref ref-type="aff" rid="I1">1</xref></contrib><contrib id="A4" contrib-type="author"><name><surname>J&#x000e4;ger</surname><given-names>Richard</given-names></name><xref ref-type="aff" rid="I1">1</xref></contrib><contrib id="A5" corresp="yes" contrib-type="author"><name><surname>Schorle</surname><given-names>Hubert</given-names></name><xref ref-type="aff" rid="I1">1</xref><email>Hubert.Schorle@ukb.uni-bonn.de</email></contrib></contrib-group><aff id="I1"><label>1</label>Department of Developmental Pathology, Institute of Pathology, Sigmund-Freud Strasse 25, 53125 Bonn, Germany</aff><pub-date pub-type="ppub"><year>2005</year></pub-date><pub-date pub-type="epub"><day>28</day><month>12</month><year>2005</year></pub-date><volume>6</volume><issue>13</issue><fpage>246</fpage><lpage>246</lpage><ext-link ext-link-type="uri" xlink:href="http://genomebiology.com/2005/6/13/246"/><copyright-statement>Copyright &#x000a9; 2005 BioMed Central Ltd</copyright-statement><abstract abstract-type="short"><p>AP-2 transcription factors are involved in cell-type-specific stimulation of proliferation and the suppression of terminal differentiation during embryonic development. Members of the family are found in mammals (with five different proteins in human and mice), frogs and fish, as well as protochordates, insects and nematodes.</p></abstract><abstract><p>The AP-2 family of transcription factors consists of five different proteins in humans and mice: AP-2&#x003b1;, AP-2&#x003b2;, AP-2&#x003b3;, AP-2&#x003b4; and AP-2&#x003b5;. Frogs and fish have known orthologs of some but not all of these proteins, and homologs of the family are also found in protochordates, insects and nematodes. The proteins have a characteristic helix-span-helix motif at the carboxyl terminus, which, together with a central basic region, mediates dimerization and DNA binding. The amino terminus contains the transactivation domain. AP-2 proteins are first expressed in primitive ectoderm of invertebrates and vertebrates; in vertebrates, they are also expressed in the emerging neural-crest cells, and <italic>AP-2&#x003b1;</italic><sup>-/- </sup>animals have impairments in neural-crest-derived facial structures. AP-2&#x003b2; is indispensable for kidney development and AP-2&#x003b3; is necessary for the formation of trophectoderm cells shortly after implantation; AP-2&#x003b1; and AP-2&#x003b3; levels are elevated in human mammary carcinoma and seminoma. The general functions of the family appear to be the cell-type-specific stimulation of proliferation and the suppression of terminal differentiation during embryonic development.</p></abstract></article-meta></front><body><sec><title>Gene organization and evolutionary history</title><p>The AP-2 family of transcription factors (Ensembl Family ENSF00000001105) consists in humans and mice of five members, AP-2&#x003b1;, AP-2&#x003b2;, AP-2&#x003b3;, AP-2&#x003b4; and AP-2&#x003b5;; frogs and fish have some of these proteins, and homologs are also known in invertebrates. The chromosomal locations and accession numbers of the family are given in Tables <xref ref-type="table" rid="T1">1</xref> and <xref ref-type="table" rid="T2">2</xref>, respectively. All mammalian AP-2 proteins except AP-2&#x003b4; are encoded by seven exons and share a characteristic domain structure (reviewed in [<xref ref-type="bibr" rid="B1">1</xref>]; for AP-2&#x003b4; see [<xref ref-type="bibr" rid="B2">2</xref>] and for AP-2&#x003b5; see [<xref ref-type="bibr" rid="B3">3</xref>,<xref ref-type="bibr" rid="B4">4</xref>]). Orthologs show a similarity between 60 and 99% at the amino-acid level, whereas paralogs show a similarity between 56 and 78%.</p><p>Analysis of the phylogenetic tree (Figure <xref ref-type="fig" rid="F1">1</xref>) reveals that the vertebrate AP-2 proteins are grouped together and are divided into five groups. The single <italic>Xenopus </italic>AP-2 is most closely related to mammalian AP-2&#x003b1; proteins. As the genes <italic>AP-2&#x003b2; </italic>and <italic>AP-2&#x003b4; </italic>are found on the same chromosome in chickens, rodents and humans (Table <xref ref-type="table" rid="T1">1</xref>), it is likely that they are the result of an internal duplication. According to the phylogenetic tree, <italic>AP-2&#x003b4; </italic>genes appear to have separated from the rest of the family early in the vertebrate clade and to have evolved separately (Figure <xref ref-type="fig" rid="F1">1</xref>). A BLAST search of the puffer fish <italic>Fugu rubripes </italic>fourth genome assembly database [<xref ref-type="bibr" rid="B5">5</xref>] suggests that there are orthologs of <italic>AP-2&#x003b1;</italic>, <italic>AP-2&#x003b2;</italic>, <italic>AP-2&#x003b3; </italic>and <italic>AP-2&#x003b5; </italic>but not <italic>AP-2&#x003b4; </italic>genes in bony fish, although only orthologs of <italic>AP-2&#x003b1; </italic>and <italic>AP-2&#x003b2; </italic>have been found in zebrafish.</p><p>In the genome of the protochordate <italic>Ciona intestinalis </italic>a single <italic>AP-2 </italic>gene has been predicted; the phylogenetic tree shows that the protein evolved before the split of the AP-2&#x003b1;, AP-2&#x003b2;, AP-2&#x003b3; and AP-2&#x003b5; proteins, with the highest sequence similarity with the AP-2&#x003b1; group, suggesting that AP-2&#x003b1; might be most similar to the ancestor of AP-2 proteins. This hypothesis is further supported by the conserved epithelial expression patterns of murine <italic>AP-2&#x003b1;</italic>[<xref ref-type="bibr" rid="B6">6</xref>], <italic>Xenopus AP-2 </italic>[<xref ref-type="bibr" rid="B7">7</xref>] and the amphioxus and lamprey <italic>AP-2</italic>[<xref ref-type="bibr" rid="B8">8</xref>] genes. As expected, the two <italic>Caenorhabditis elegans </italic>and the single <italic>Drosophila melanogaster </italic>AP-2 proteins show the weakest phylogenetic relationship with vertebrate and protochordate AP-2 transcription factors; they form an outgroup to the other AP-2 family members (Figure <xref ref-type="fig" rid="F1">1</xref>). Given that no <italic>AP-2 </italic>gene has been identified in yeast, the family probably originated late in evolution and expanded considerably in the vertebrates.</p></sec><sec><title>Characteristic structural features</title><p>All AP-2 proteins share a highly conserved helix-span-helix dimerization motif at the carboxyl terminus, followed by a central basic region and a less conserved domain rich in proline and glutamine at the amino terminus (Figure <xref ref-type="fig" rid="F2">2</xref>). The proteins are able to form hetero- as well as homodimers. The helix-span-helix motif together with the basic region mediates DNA binding [<xref ref-type="bibr" rid="B9">9</xref>,<xref ref-type="bibr" rid="B10">10</xref>], and the proline- and glutamine-rich region is responsible for transactivation. AP-2 has been shown to bind to the palindromic consensus sequence 5'-GCCN<sub>3</sub>GGC-3', found in various cellular and viral enhancers (reviewed in [<xref ref-type="bibr" rid="B1">1</xref>]); a binding-site selection assay <italic>in vitro </italic>also revealed the additional binding motifs 5'-GCCN<sub>3</sub>GGC-3', 5'-GCCN<sub>4</sub>GGC-3' and 5'-GCCN<sub>3/4</sub>GGG-3' [<xref ref-type="bibr" rid="B11">11</xref>]. Other binding sites differing from these sequence motifs, for example, the SV40 enhancer element 5'-CCCCAGGC-3' [<xref ref-type="bibr" rid="B12">12</xref>], indicate that AP-2 proteins may bind to a range of G/C-rich elements with variable affinities. Target genes with AP-2-binding sites in their promoter sequences are involved in biological processes such as cell growth and differentiation and include, for example, those encoding insulin-like growth factor binding protein 5 (<italic>IGF-BP5</italic>) with the binding site 5'-GCCAGGGGC-3' [<xref ref-type="bibr" rid="B13">13</xref>], prothymosin-&#x003b1; (5'-GCCGGTGGGC-3') [<xref ref-type="bibr" rid="B14">14</xref>] and the estrogen receptor (5'-GCCTGCGGGG-3') [<xref ref-type="bibr" rid="B15">15</xref>].</p><p>Most AP-2 proteins have a PY motif (XPPXY) and other highly conserved critical residues in the transactivation domain; by contrast, the PY motif is missing in AP-2&#x003b4; but the amino- and carboxy-terminal ends of the core sequence of the transactivation domain are still conserved. In addition, the binding affinity of AP-2&#x003b4; to conserved AP-2-binding sites is much lower than that of other AP-2 proteins [<xref ref-type="bibr" rid="B2">2</xref>]. This suggests that AP-2&#x003b4; might transactivate genes <italic>in vivo </italic>by a different mechanism from that used by other AP-2 proteins, probably through interactions with a novel group of coactivators and through a different affinity for AP-2-binding sites. Alternatively, AP-2&#x003b4; might act as a negative regulator, inhibiting or modulating the transactivation capability or DNA-binding affinity of the other AP-2 family members. The crystal structure of the AP-2 proteins has not yet been solved.</p></sec><sec><title>Localization and function</title><p>AP-2 transcription factors are localized predominantly in the nucleus, where they bind to target sequences and regulate transcription of target genes. AP-2 proteins have also been shown to interfere with other signal transduction pathways; for example, it has been proposed that they modulate the pathway downstream of the developmental signaling molecule Wnt by associating with the Adenomatous polyposis coli (APC) tumor suppressor protein in the nucleus [<xref ref-type="bibr" rid="B16">16</xref>].</p><p>The activity of AP-2 proteins can be controlled at multiple levels: their transactivation potential, their DNA binding, their subcellular localization [<xref ref-type="bibr" rid="B17">17</xref>-<xref ref-type="bibr" rid="B19">19</xref>] and their degradation [<xref ref-type="bibr" rid="B20">20</xref>,<xref ref-type="bibr" rid="B21">21</xref>] can all be modified. Mechanisms of regulation include post-translational modifications, such as protein kinase A-mediated phosphorylation [<xref ref-type="bibr" rid="B22">22</xref>,<xref ref-type="bibr" rid="B23">23</xref>], sumoylation [<xref ref-type="bibr" rid="B24">24</xref>] and redox regulation [<xref ref-type="bibr" rid="B25">25</xref>,<xref ref-type="bibr" rid="B26">26</xref>], as well as physical interaction with various proteins (see Table <xref ref-type="table" rid="T3">3</xref> for a comprehensive list). Interacting proteins either modulate the activity of AP-2 proteins or are influenced in their function by binding to AP-2 proteins.</p><p>The tissue distribution and developmental functions of AP-2 transcription factors have been studied extensively in several species. <italic>Drosophila AP-2 </italic>(<italic>dAP-2</italic>) is expressed in the maxillary segment and neural structures during embryogenesis, and in the central nervous system (CNS) and the leg, antennal and labial imaginal disks during larval development [<xref ref-type="bibr" rid="B27">27</xref>,<xref ref-type="bibr" rid="B28">28</xref>]. Mutation of the <italic>dAP-2 </italic>gene leads to defects in proboscis development and leg-joint formation [<xref ref-type="bibr" rid="B29">29</xref>,<xref ref-type="bibr" rid="B30">30</xref>].</p><p>The multiple overlapping and diverging expression patterns of AP-2 family proteins suggest that, following the expansion of the family during vertebrate evolution, redundant and non-redundant functions of the individual AP-2 family members evolved. Although the single AP-2 protein in the cephalochordate amphioxus is expressed mainly in non-neuronal ectoderm, in the lamprey, a primitive vertebrate, AP-2 has co-opted a second expression domain, the neural crest [<xref ref-type="bibr" rid="B8">8</xref>]. The single AP-2 homolog described so far in <italic>Xenopus </italic>is expressed in the epidermis and neural crest and has been shown to be critical for the development of these structures [<xref ref-type="bibr" rid="B7">7</xref>,<xref ref-type="bibr" rid="B31">31</xref>-<xref ref-type="bibr" rid="B33">33</xref>]. In zebrafish, the two AP-2 family members, <italic>tfap2a </italic>and <italic>tfap2b </italic>[<xref ref-type="bibr" rid="B34">34</xref>], are coexpressed in the neural tube, the ectoderm and the pronephric ducts of the developing kidney, but only <italic>tfap2a </italic>is expressed in neural crest cells [<xref ref-type="bibr" rid="B35">35</xref>,<xref ref-type="bibr" rid="B36">36</xref>]. Positional cloning revealed that the zebrafish point mutants named <italic>mont blanc </italic>[<xref ref-type="bibr" rid="B35">35</xref>] and <italic>lockjaw </italic>[<xref ref-type="bibr" rid="B36">36</xref>] encode <italic>tfap2a</italic>; the mutant animals display impaired development of neural-crest derivatives, such as the facial skeleton, the peripheral nervous system and pigment cells [<xref ref-type="bibr" rid="B37">37</xref>,<xref ref-type="bibr" rid="B38">38</xref>]. It is also interesting to note that AP-2 proteins are expressed in the primitive ectoderm of both invertebrates and vertebrates, suggesting an evolutionarily conserved role for the family in the formation of this tissue.</p><p>In mice, three of the five AP-2 family members (<italic>AP-2&#x003b1;</italic>, <italic>AP-2&#x003b2; </italic>and <italic>AP-2&#x003b3;</italic>) are coexpressed in neural-crest cells, the peripheral nervous system, facial and limb mesenchyme, various epithelia of the developing embryo and the extraembryonic trophectoderm [<xref ref-type="bibr" rid="B2">2</xref>,<xref ref-type="bibr" rid="B39">39</xref>-<xref ref-type="bibr" rid="B41">41</xref>]. <italic>AP-2&#x003b4; </italic>expression is restricted mainly to the developing heart, CNS and retina [<xref ref-type="bibr" rid="B39">39</xref>], whereas <italic>AP-2&#x003b5; </italic>expression is detected in cells of the olfactory bulb [<xref ref-type="bibr" rid="B3">3</xref>,<xref ref-type="bibr" rid="B4">4</xref>]. Despite the overlapping expression patterns of <italic>AP-2&#x003b1;</italic>, <italic>AP-2&#x003b2; </italic>and <italic>AP-2&#x003b3;</italic>, disruption of these <italic>AP-2</italic> genes reveals non-redundant roles during development. Mutation of <italic>AP-2&#x003b1; </italic>predominantly affects the cranial neural crest and the limb mesenchyme, leading to disturbances of facial and limb development in a manner reminiscent of the defects described in <italic>dAP2 </italic>mutant flies [<xref ref-type="bibr" rid="B42">42</xref>,<xref ref-type="bibr" rid="B43">43</xref>]. <italic>AP-2&#x003b2; </italic>and <italic>AP-2&#x003b3;</italic>, on the other hand, are essential for kidney development [<xref ref-type="bibr" rid="B44">44</xref>,<xref ref-type="bibr" rid="B45">45</xref>] or placentation of the embryo [<xref ref-type="bibr" rid="B46">46</xref>,<xref ref-type="bibr" rid="B47">47</xref>], respectively. In humans, mutations generating a dominant negative allele of <italic>AP-2&#x003b2; </italic>have been shown to be the cause of Char syndrome (Online Mendelian Inheritance in Man (OMIM) ID 169100 [<xref ref-type="bibr" rid="B48">48</xref>]); the hallmarks of this syndrome are patent ductus arteriosus (abnormal persistence of a normal fetal heart structure after birth) with facial dysmorphism and abnormal fifth digits [<xref ref-type="bibr" rid="B49">49</xref>,<xref ref-type="bibr" rid="B50">50</xref>].</p><p>Comparing all mutant phenotypes, it can be seen that loss of AP-2 transcription factor activity generally impairs proliferation and induces premature differentiation and/or apoptosis in various cell types during development. This conclusion is further substantiated by results from a screen for AP-2&#x003b1; target genes [<xref ref-type="bibr" rid="B51">51</xref>] and supported by gain-of-function studies in <italic>Xenopus </italic>and mice [<xref ref-type="bibr" rid="B31">31</xref>,<xref ref-type="bibr" rid="B52">52</xref>,<xref ref-type="bibr" rid="B53">53</xref>]. As uncontrolled proliferation leads to malignancies, AP-2 transcription factors are not only implicated in normal development, but also seem to be involved in cellular neoplasia, and enhanced AP-2 levels have been reported in various types of cancer [<xref ref-type="bibr" rid="B19">19</xref>,<xref ref-type="bibr" rid="B54">54</xref>-<xref ref-type="bibr" rid="B60">60</xref>]. In a murine breast-cancer model, tumor progression is enhanced after transgenic overexpression of <italic>AP-2&#x003b3; </italic>[<xref ref-type="bibr" rid="B55">55</xref>]. Thus, AP-2 proteins can be viewed as gatekeepers controlling the balance between proliferation and differentiation during embryogenesis.</p></sec><sec><title>Frontiers</title><p>The lethal phenotypes of the AP-2 mutants generated so far have precluded an analysis of the roles of AP-2 transcription factors in adult tissues. We and others are currently exploiting the power of conditional mouse mutants to overcome these restrictions [<xref ref-type="bibr" rid="B61">61</xref>-<xref ref-type="bibr" rid="B63">63</xref>]. Such approaches will not only shed light on normal AP-2 functions but will probably also lead to unique insights into human disorders.</p><p>Complementary approaches currently include the identification of AP-2 target genes; this might give a better understanding of developmental disturbances and pave the way to novel treatment options [<xref ref-type="bibr" rid="B51">51</xref>,<xref ref-type="bibr" rid="B64">64</xref>]. At the molecular level, one major challenge will be the identification of specific AP-2 homo- or hetero-dimeric complexes bound to a particular promoter and the identification of the specific properties of each complex with respect to gene regulation. Also, the signaling pathways responsible for induction of <italic>AP-2 </italic>genes are currently under investigation. A cross-species comparison of the various <italic>AP-2 </italic>promoters may give insights into the evolution of tissue specificity and help to determine important enhancer elements. Moreover, given that CpG islands are present in <italic>AP-2 </italic>promoters, epigenetic regulation such as DNA methylation also needs to be considered.</p><p>AP-2 transcription factors are currently being studied extensively in human cancer, and they may be of diagnostic value, as has been demonstrated for mammary or testicular carcinoma [<xref ref-type="bibr" rid="B19">19</xref>,<xref ref-type="bibr" rid="B54">54</xref>,<xref ref-type="bibr" rid="B56">56</xref>,<xref ref-type="bibr" rid="B65">65</xref>,<xref ref-type="bibr" rid="B66">66</xref>]. It is tempting to speculate that AP-2 transcription factors might not only be molecular markers for certain types of cancer, but could also be causally involved in their etiologies and would therefore represent a potential target for therapeutic intervention.</p></sec></body><back><ack><sec><title>Acknowledgements</title><p>We thank Roland Dosch and Michael Pankratz for critical reading of the manuscript. This work was supported by funding from the Deutsche Forschungsgemeinschaft (# 503/6 and 503/7) that was awarded to H.S.</p></sec></ack><ref-list><ref id="B1"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Hilger-Eversheim</surname><given-names>K</given-names></name><name><surname>Moser</surname><given-names>M</given-names></name><name><surname>Schorle</surname><given-names>H</given-names></name><name><surname>Buettner</surname><given-names>R</given-names></name></person-group><article-title>Regulatory roles of AP-2 transcription factors in vertebrate development, apoptosis and cell-cycle control.</article-title><source>Gene</source><year>2000</year><volume>260</volume><fpage>1</fpage><lpage>12</lpage><pub-id pub-id-type="pmid">11137286</pub-id><pub-id pub-id-type="doi">10.1016/S0378-1119(00)00454-6</pub-id></citation></ref><ref id="B2"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Zhao</surname><given-names>F</given-names></name><name><surname>Satoda</surname><given-names>M</given-names></name><name><surname>Licht</surname><given-names>JD</given-names></name><name><surname>Hayashizaki</surname><given-names>Y</given-names></name><name><surname>Gelb</surname><given-names>BD</given-names></name></person-group><article-title>Cloning and characterization of a novel mouse AP-2 transcription factor, AP-2delta, with unique DNA binding and transactivation properties.</article-title><source>J Biol Chem</source><year>2001</year><volume>276</volume><fpage>40755</fpage><lpage>40760</lpage><pub-id pub-id-type="pmid">11522791</pub-id><pub-id pub-id-type="doi">10.1074/jbc.M106284200</pub-id></citation></ref><ref id="B3"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Wang</surname><given-names>HV</given-names></name><name><surname>Vaupel</surname><given-names>K</given-names></name><name><surname>Buettner</surname><given-names>R</given-names></name><name><surname>Bosserhoff</surname><given-names>AK</given-names></name><name><surname>Moser</surname><given-names>M</given-names></name></person-group><article-title>Identification and embryonic expression of a new AP-2 transcription factor, AP-2 epsilon.</article-title><source>Dev Dyn</source><year>2004</year><volume>231</volume><fpage>128</fpage><lpage>135</lpage><pub-id pub-id-type="pmid">15305293</pub-id><pub-id pub-id-type="doi">10.1002/dvdy.20119</pub-id></citation></ref><ref id="B4"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Feng</surname><given-names>W</given-names></name><name><surname>Williams</surname><given-names>T</given-names></name></person-group><article-title>Cloning and characterization of the mouse AP-2 epsilon gene: a novel family member expressed in the developing olfactory bulb.</article-title><source>Mol Cell Neurosci</source><year>2003</year><volume>24</volume><fpage>460</fpage><lpage>475</lpage><pub-id pub-id-type="pmid">14572467</pub-id><pub-id pub-id-type="doi">10.1016/S1044-7431(03)00209-4</pub-id></citation></ref><ref id="B5"><citation citation-type="other"><article-title>IMCB - Fugu Genome Project</article-title><ext-link ext-link-type="uri" xlink:href="http://www.fugu-sg.org/"/></citation></ref><ref id="B6"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Mitchell</surname><given-names>PJ</given-names></name><name><surname>Timmons</surname><given-names>PM</given-names></name><name><surname>Hebert</surname><given-names>JM</given-names></name><name><surname>Rigby</surname><given-names>PW</given-names></name><name><surname>Tjian</surname><given-names>R</given-names></name></person-group><article-title>Transcription factor AP-2 is expressed in neural crest cell lineages during mouse embryogenesis.</article-title><source>Genes Dev</source><year>1991</year><volume>5</volume><fpage>105</fpage><lpage>119</lpage><pub-id pub-id-type="pmid">1989904</pub-id></citation></ref><ref id="B7"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Snape</surname><given-names>AM</given-names></name><name><surname>Winning</surname><given-names>RS</given-names></name><name><surname>Sargent</surname><given-names>TD</given-names></name></person-group><article-title>Transcription factor AP-2 is tissue-specific in <italic>Xenopus </italic>and is closely related or identical to keratin transcription factor 1 (KTF-1).</article-title><source>Development</source><year>1991</year><volume>113</volume><fpage>283</fpage><lpage>293</lpage><pub-id pub-id-type="pmid">1722450</pub-id></citation></ref><ref id="B8"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Meulemans</surname><given-names>D</given-names></name><name><surname>Bronner-Fraser</surname><given-names>M</given-names></name></person-group><article-title>Amphioxus and lamprey AP-2 genes: implications for neural crest evolution and migration patterns.</article-title><source>Development</source><year>2002</year><volume>129</volume><fpage>4953</fpage><lpage>4962</lpage><pub-id pub-id-type="pmid">12397104</pub-id></citation></ref><ref id="B9"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Williams</surname><given-names>T</given-names></name><name><surname>Tjian</surname><given-names>R</given-names></name></person-group><article-title>Analysis of the DNA-binding and activation properties of the human transcription factor AP-2.</article-title><source>Genes Dev</source><year>1991</year><volume>5</volume><fpage>670</fpage><lpage>682</lpage><pub-id pub-id-type="pmid">2010091</pub-id></citation></ref><ref id="B10"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Williams</surname><given-names>T</given-names></name><name><surname>Tjian</surname><given-names>R</given-names></name></person-group><article-title>Characterization of a dimerization motif in AP-2 and its function in heterologous DNA-binding proteins.</article-title><source>Science</source><year>1991</year><volume>251</volume><fpage>1067</fpage><lpage>1071</lpage><pub-id pub-id-type="pmid">1998122</pub-id></citation></ref><ref id="B11"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Mohibullah</surname><given-names>N</given-names></name><name><surname>Donner</surname><given-names>A</given-names></name><name><surname>Ippolito</surname><given-names>JA</given-names></name><name><surname>Williams</surname><given-names>T</given-names></name></person-group><article-title>SELEX and missing phosphate contact analyses reveal flexibility within the AP-2[alpha] protein: DNA binding complex.</article-title><source>Nucleic Acids Res</source><year>1999</year><volume>27</volume><fpage>2760</fpage><lpage>2769</lpage><pub-id pub-id-type="pmid">10373594</pub-id><pub-id pub-id-type="doi">10.1093/nar/27.13.2760</pub-id></citation></ref><ref id="B12"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Mitchell</surname><given-names>PJ</given-names></name><name><surname>Wang</surname><given-names>C</given-names></name><name><surname>Tjian</surname><given-names>R</given-names></name></person-group><article-title>Positive and negative regulation of transcription <italic>in vitro</italic>: enhancer-binding protein AP-2 is inhibited by SV40 T antigen.</article-title><source>Cell</source><year>1987</year><volume>50</volume><fpage>847</fpage><lpage>861</lpage><pub-id pub-id-type="pmid">3040262</pub-id><pub-id pub-id-type="doi">10.1016/0092-8674(87)90512-5</pub-id></citation></ref><ref id="B13"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Duan</surname><given-names>C</given-names></name><name><surname>Clemmons</surname><given-names>DR</given-names></name></person-group><article-title>Transcription factor AP-2 regulates human insulin-like growth factor binding protein-5 gene expression.</article-title><source>J Biol Chem</source><year>1995</year><volume>270</volume><fpage>24844</fpage><lpage>24851</lpage><pub-id pub-id-type="pmid">7559606</pub-id><pub-id pub-id-type="doi">10.1074/jbc.270.42.24844</pub-id></citation></ref><ref id="B14"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Gaubatz</surname><given-names>S</given-names></name><name><surname>Imhof</surname><given-names>A</given-names></name><name><surname>Dosch</surname><given-names>R</given-names></name><name><surname>Werner</surname><given-names>O</given-names></name><name><surname>Mitchell</surname><given-names>P</given-names></name><name><surname>Buettner</surname><given-names>R</given-names></name><name><surname>Eilers</surname><given-names>M</given-names></name></person-group><article-title>Transcriptional activation by Myc is under negative control by the transcription factor AP-2.</article-title><source>EMBO J</source><year>1995</year><volume>14</volume><fpage>1508</fpage><lpage>1519</lpage><pub-id pub-id-type="pmid">7729426</pub-id></citation></ref><ref id="B15"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Newman</surname><given-names>SP</given-names></name><name><surname>Bates</surname><given-names>NP</given-names></name><name><surname>Vernimmen</surname><given-names>D</given-names></name><name><surname>Parker</surname><given-names>MG</given-names></name><name><surname>Hurst</surname><given-names>HC</given-names></name></person-group><article-title>Cofactor competition between the ligand-bound oestrogen receptor and an intron 1 enhancer leads to oestrogen repression of ERBB2 expression in breast cancer.</article-title><source>Oncogene</source><year>2000</year><volume>19</volume><fpage>490</fpage><lpage>497</lpage><pub-id pub-id-type="pmid">10698518</pub-id><pub-id pub-id-type="doi">10.1038/sj.onc.1203416</pub-id></citation></ref><ref id="B16"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Li</surname><given-names>Q</given-names></name><name><surname>Dashwood</surname><given-names>RH</given-names></name></person-group><article-title>Activator protein 2alpha associates with adenomatous polyposis coli/beta-catenin and inhibits beta-catenin/T-cell factor transcriptional activity in colorectal cancer cells.</article-title><source>J Biol Chem</source><year>2004</year><volume>279</volume><fpage>45669</fpage><lpage>45675</lpage><pub-id pub-id-type="pmid">15331612</pub-id><pub-id pub-id-type="doi">10.1074/jbc.M405025200</pub-id></citation></ref><ref id="B17"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Aqeilan</surname><given-names>RI</given-names></name><name><surname>Palamarchuk</surname><given-names>A</given-names></name><name><surname>Weigel</surname><given-names>RJ</given-names></name><name><surname>Herrero</surname><given-names>JJ</given-names></name><name><surname>Pekarsky</surname><given-names>Y</given-names></name><name><surname>Croce</surname><given-names>CM</given-names></name></person-group><article-title>Physical and functional interactions between the Wwox tumor suppressor protein and the AP-2gamma transcription factor.</article-title><source>Cancer Res</source><year>2004</year><volume>64</volume><fpage>8256</fpage><lpage>8261</lpage><pub-id pub-id-type="pmid">15548692</pub-id><pub-id pub-id-type="doi">10.1158/0008-5472.CAN-04-2055</pub-id></citation></ref><ref id="B18"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Mazina</surname><given-names>OM</given-names></name><name><surname>Phillips</surname><given-names>MA</given-names></name><name><surname>Williams</surname><given-names>T</given-names></name><name><surname>Vines</surname><given-names>CA</given-names></name><name><surname>Cherr</surname><given-names>GN</given-names></name><name><surname>Rice</surname><given-names>RH</given-names></name></person-group><article-title>Redistribution of transcription factor AP-2alpha in differentiating cultured human epidermal cells.</article-title><source>J Invest Dermatol</source><year>2001</year><volume>117</volume><fpage>864</fpage><lpage>870</lpage><pub-id pub-id-type="pmid">11676824</pub-id><pub-id pub-id-type="doi">10.1046/j.0022-202x.2001.01472.x</pub-id></citation></ref><ref id="B19"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Pellikainen</surname><given-names>J</given-names></name><name><surname>Naukkarinen</surname><given-names>A</given-names></name><name><surname>Ropponen</surname><given-names>K</given-names></name><name><surname>Rummukainen</surname><given-names>J</given-names></name><name><surname>Kataja</surname><given-names>V</given-names></name><name><surname>Kellokoski</surname><given-names>J</given-names></name><name><surname>Eskelinen</surname><given-names>M</given-names></name><name><surname>Kosma</surname><given-names>VM</given-names></name></person-group><article-title>Expression of HER2 and its association with AP-2 in breast cancer.</article-title><source>Eur J Cancer</source><year>2004</year><volume>40</volume><fpage>1485</fpage><lpage>1495</lpage><pub-id pub-id-type="pmid">15196531</pub-id><pub-id pub-id-type="doi">10.1016/j.ejca.2004.02.020</pub-id></citation></ref><ref id="B20"><citation citation-type="other"><person-group person-group-type="author"><name><surname>Li</surname><given-names>M</given-names></name><name><surname>Wang</surname><given-names>Y</given-names></name><name><surname>Hung</surname><given-names>MC</given-names></name><name><surname>Kannan</surname><given-names>P</given-names></name></person-group><article-title>Inefficient proteasomal-degradation pathway stabilizes AP-2alpha and activates HER-2/neu gene in breast cancer.</article-title><source>Int J Cancer</source><year>2005</year><comment>doi:10.1002/ijc.21426.</comment></citation></ref><ref id="B21"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Nyormoi</surname><given-names>O</given-names></name><name><surname>Wang</surname><given-names>Z</given-names></name><name><surname>Doan</surname><given-names>D</given-names></name><name><surname>Ruiz</surname><given-names>M</given-names></name><name><surname>McConkey</surname><given-names>D</given-names></name><name><surname>Bar-Eli</surname><given-names>M</given-names></name></person-group><article-title>Transcription factor AP-2alpha is preferentially cleaved by caspase 6 and degraded by proteasome during tumor necrosis factor alpha-induced apoptosis in breast cancer cells.</article-title><source>Mol Cell Biol</source><year>2001</year><volume>21</volume><fpage>4856</fpage><lpage>4867</lpage><pub-id pub-id-type="pmid">11438643</pub-id><pub-id pub-id-type="doi">10.1128/MCB.21.15.4856-4867.2001</pub-id></citation></ref><ref id="B22"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Garcia</surname><given-names>MA</given-names></name><name><surname>Campillos</surname><given-names>M</given-names></name><name><surname>Marina</surname><given-names>A</given-names></name><name><surname>Valdivieso</surname><given-names>F</given-names></name><name><surname>Vazquez</surname><given-names>J</given-names></name></person-group><article-title>Transcription factor AP-2 activity is modulated by protein kinase A-mediated phosphorylation.</article-title><source>FEBS Lett</source><year>1999</year><volume>444</volume><fpage>27</fpage><lpage>31</lpage><pub-id pub-id-type="pmid">10037142</pub-id><pub-id pub-id-type="doi">10.1016/S0014-5793(99)00021-6</pub-id></citation></ref><ref id="B23"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Park</surname><given-names>K</given-names></name><name><surname>Kim</surname><given-names>KH</given-names></name></person-group><article-title>The site of cAMP action in the insulin induction of gene expression of acetyl-CoA carboxylase is AP-2.</article-title><source>J Biol Chem</source><year>1993</year><volume>268</volume><fpage>17811</fpage><lpage>17819</lpage><pub-id pub-id-type="pmid">8102369</pub-id></citation></ref><ref id="B24"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Zhong</surname><given-names>L</given-names></name><name><surname>Wang</surname><given-names>Y</given-names></name><name><surname>Kannan</surname><given-names>P</given-names></name><name><surname>Tainsky</surname><given-names>MA</given-names></name></person-group><article-title>Functional characterization of the interacting domains of the positive coactivator PC4 with the transcription factor AP-2alpha.</article-title><source>Gene</source><year>2003</year><volume>320</volume><fpage>155</fpage><lpage>164</lpage><pub-id pub-id-type="pmid">14597399</pub-id><pub-id pub-id-type="doi">10.1016/S0378-1119(03)00823-0</pub-id></citation></ref><ref id="B25"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Grether-Beck</surname><given-names>S</given-names></name><name><surname>Felsner</surname><given-names>I</given-names></name><name><surname>Brenden</surname><given-names>H</given-names></name><name><surname>Krutmann</surname><given-names>J</given-names></name></person-group><article-title>Mitochondrial cytochrome c release mediates ceramide-induced activator protein 2 activation and gene expression in keratinocytes.</article-title><source>J Biol Chem</source><year>2003</year><volume>278</volume><fpage>47498</fpage><lpage>47507</lpage><pub-id pub-id-type="pmid">12952965</pub-id><pub-id pub-id-type="doi">10.1074/jbc.M309511200</pub-id></citation></ref><ref id="B26"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Huang</surname><given-names>Y</given-names></name><name><surname>Domann</surname><given-names>FE</given-names></name></person-group><article-title>Redox modulation of AP-2 DNA binding activity <italic>in vitro</italic>.</article-title><source>Biochem Biophys Res Commun</source><year>1998</year><volume>249</volume><fpage>307</fpage><lpage>312</lpage><pub-id pub-id-type="pmid">9712692</pub-id><pub-id pub-id-type="doi">10.1006/bbrc.1998.9139</pub-id></citation></ref><ref id="B27"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Bauer</surname><given-names>R</given-names></name><name><surname>McGuffin</surname><given-names>ME</given-names></name><name><surname>Mattox</surname><given-names>W</given-names></name><name><surname>Tainsky</surname><given-names>MA</given-names></name></person-group><article-title>Cloning and characterization of the <italic>Drosophila </italic>homologue of the AP-2 transcription factor.</article-title><source>Oncogene</source><year>1998</year><volume>17</volume><fpage>1911</fpage><lpage>1922</lpage><pub-id pub-id-type="pmid">9788434</pub-id><pub-id pub-id-type="doi">10.1038/sj.onc.1202114</pub-id></citation></ref><ref id="B28"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Monge</surname><given-names>I</given-names></name><name><surname>Mitchell</surname><given-names>PJ</given-names></name></person-group><article-title>DAP-2, the <italic>Drosophila </italic>homolog of transcription factor AP-2.</article-title><source>Mech Dev</source><year>1998</year><volume>76</volume><fpage>191</fpage><lpage>195</lpage><pub-id pub-id-type="pmid">9867351</pub-id><pub-id pub-id-type="doi">10.1016/S0925-4773(98)00125-7</pub-id></citation></ref><ref id="B29"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Kerber</surname><given-names>B</given-names></name><name><surname>Monge</surname><given-names>I</given-names></name><name><surname>Mueller</surname><given-names>M</given-names></name><name><surname>Mitchell</surname><given-names>PJ</given-names></name><name><surname>Cohen</surname><given-names>SM</given-names></name></person-group><article-title>The AP-2 transcription factor is required for joint formation and cell survival in <italic>Drosophila </italic>leg development.</article-title><source>Development</source><year>2001</year><volume>128</volume><fpage>1231</fpage><lpage>1238</lpage><pub-id pub-id-type="pmid">11262225</pub-id></citation></ref><ref id="B30"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Monge</surname><given-names>I</given-names></name><name><surname>Krishnamurthy</surname><given-names>R</given-names></name><name><surname>Sims</surname><given-names>D</given-names></name><name><surname>Hirth</surname><given-names>F</given-names></name><name><surname>Spengler</surname><given-names>M</given-names></name><name><surname>Kammermeier</surname><given-names>L</given-names></name><name><surname>Reichert</surname><given-names>H</given-names></name><name><surname>Mitchell</surname><given-names>PJ</given-names></name></person-group><article-title><italic>Drosophila </italic>transcription factor AP-2 in proboscis, leg and brain central complex development.</article-title><source>Development</source><year>2001</year><volume>128</volume><fpage>1239</fpage><lpage>1252</lpage><pub-id pub-id-type="pmid">11262226</pub-id></citation></ref><ref id="B31"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Luo</surname><given-names>T</given-names></name><name><surname>Matsuo-Takasaki</surname><given-names>M</given-names></name><name><surname>Thomas</surname><given-names>ML</given-names></name><name><surname>Weeks</surname><given-names>DL</given-names></name><name><surname>Sargent</surname><given-names>TD</given-names></name></person-group><article-title>Transcription factor AP-2 is an essential and direct regulator of epidermal development in <italic>Xenopus</italic>.</article-title><source>Dev Biol</source><year>2002</year><volume>245</volume><fpage>136</fpage><lpage>144</lpage><pub-id pub-id-type="pmid">11969261</pub-id><pub-id pub-id-type="doi">10.1006/dbio.2002.0621</pub-id></citation></ref><ref id="B32"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Winning</surname><given-names>RS</given-names></name><name><surname>Shea</surname><given-names>LJ</given-names></name><name><surname>Marcus</surname><given-names>SJ</given-names></name><name><surname>Sargent</surname><given-names>TD</given-names></name></person-group><article-title>Developmental regulation of transcription factor AP-2 during <italic>Xenopus laevis </italic>embryogenesis.</article-title><source>Nucleic Acids Res</source><year>1991</year><volume>19</volume><fpage>3709</fpage><lpage>3714</lpage><pub-id pub-id-type="pmid">1852613</pub-id></citation></ref><ref id="B33"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Luo</surname><given-names>T</given-names></name><name><surname>Lee</surname><given-names>YH</given-names></name><name><surname>Saint-Jeannet</surname><given-names>JP</given-names></name><name><surname>Sargent</surname><given-names>TD</given-names></name></person-group><article-title>Induction of neural crest in Xenopus by transcription factor AP2alpha.</article-title><source>Proc Natl Acad Sci USA</source><year>2003</year><volume>100</volume><fpage>532</fpage><lpage>537</lpage><pub-id pub-id-type="pmid">12511599</pub-id><pub-id pub-id-type="doi">10.1073/pnas.0237226100</pub-id></citation></ref><ref id="B34"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Knight</surname><given-names>RD</given-names></name><name><surname>Javidan</surname><given-names>Y</given-names></name><name><surname>Zhang</surname><given-names>T</given-names></name><name><surname>Nelson</surname><given-names>S</given-names></name><name><surname>Schilling</surname><given-names>TF</given-names></name></person-group><article-title>AP2-dependent signals from the ectoderm regulate craniofacial development in the zebrafish embryo.</article-title><source>Development</source><year>2005</year><volume>132</volume><fpage>3127</fpage><lpage>3138</lpage><pub-id pub-id-type="pmid">15944192</pub-id><pub-id pub-id-type="doi">10.1242/dev.01879</pub-id></citation></ref><ref id="B35"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Holzschuh</surname><given-names>J</given-names></name><name><surname>Barrallo-Gimeno</surname><given-names>A</given-names></name><name><surname>Ettl</surname><given-names>AK</given-names></name><name><surname>Durr</surname><given-names>K</given-names></name><name><surname>Knapik</surname><given-names>EW</given-names></name><name><surname>Driever</surname><given-names>W</given-names></name></person-group><article-title>Noradrenergic neurons in the zebrafish hindbrain are induced by retinoic acid and require tfap2a for expression of the neurotransmitter phenotype.</article-title><source>Development</source><year>2003</year><volume>130</volume><fpage>5741</fpage><lpage>5754</lpage><pub-id pub-id-type="pmid">14534139</pub-id><pub-id pub-id-type="doi">10.1242/dev.00816</pub-id></citation></ref><ref id="B36"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Knight</surname><given-names>RD</given-names></name><name><surname>Nair</surname><given-names>S</given-names></name><name><surname>Nelson</surname><given-names>SS</given-names></name><name><surname>Afshar</surname><given-names>A</given-names></name><name><surname>Javidan</surname><given-names>Y</given-names></name><name><surname>Geisler</surname><given-names>R</given-names></name><name><surname>Rauch</surname><given-names>GJ</given-names></name><name><surname>Schilling</surname><given-names>TF</given-names></name></person-group><article-title><italic>lockjaw</italic> encodes a zebrafish tfap2a required for early neural crest development.</article-title><source>Development</source><year>2003</year><volume>130</volume><fpage>5755</fpage><lpage>5768</lpage><pub-id pub-id-type="pmid">14534133</pub-id><pub-id pub-id-type="doi">10.1242/dev.00575</pub-id></citation></ref><ref id="B37"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Barrallo-Gimeno</surname><given-names>A</given-names></name><name><surname>Holzschuh</surname><given-names>J</given-names></name><name><surname>Driever</surname><given-names>W</given-names></name><name><surname>Knapik</surname><given-names>EW</given-names></name></person-group><article-title>Neural crest survival and differentiation in zebrafish depends on <italic>mont blanc</italic>/<italic>tfap2a</italic> gene function.</article-title><source>Development</source><year>2004</year><volume>131</volume><fpage>1463</fpage><lpage>1477</lpage><pub-id pub-id-type="pmid">14985255</pub-id><pub-id pub-id-type="doi">10.1242/dev.01033</pub-id></citation></ref><ref id="B38"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Knight</surname><given-names>RD</given-names></name><name><surname>Javidan</surname><given-names>Y</given-names></name><name><surname>Nelson</surname><given-names>S</given-names></name><name><surname>Zhang</surname><given-names>T</given-names></name><name><surname>Schilling</surname><given-names>T</given-names></name></person-group><article-title>Skeletal and pigment cell defects in the <italic>lockjaw</italic> mutant reveal multiple roles for zebrafish tfap2a in neural crest development.</article-title><source>Dev Dyn</source><year>2004</year><volume>229</volume><fpage>87</fpage><lpage>98</lpage><pub-id pub-id-type="pmid">14699580</pub-id><pub-id pub-id-type="doi">10.1002/dvdy.10494</pub-id></citation></ref><ref id="B39"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Zhao</surname><given-names>F</given-names></name><name><surname>Lufkin</surname><given-names>T</given-names></name><name><surname>Gelb</surname><given-names>BD</given-names></name></person-group><article-title>Expression of Tfap2d, the gene encoding the transcription factor Ap-2 delta, during mouse embryogenesis.</article-title><source>Gene Expr Patterns</source><year>2003</year><volume>3</volume><fpage>213</fpage><lpage>217</lpage><pub-id pub-id-type="pmid">12711551</pub-id><pub-id pub-id-type="doi">10.1016/S1567-133X(02)00067-4</pub-id></citation></ref><ref id="B40"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Moser</surname><given-names>M</given-names></name><name><surname>Ruschoff</surname><given-names>J</given-names></name><name><surname>Buettner</surname><given-names>R</given-names></name></person-group><article-title>Comparative analysis of AP-2 alpha and AP-2 beta gene expression during murine embryogenesis.</article-title><source>Dev Dyn</source><year>1997</year><volume>208</volume><fpage>115</fpage><lpage>124</lpage><pub-id pub-id-type="pmid">8989526</pub-id><pub-id pub-id-type="doi">10.1002/(SICI)1097-0177(199701)208:1&#x0003c;115::AID-AJA11&#x0003e;3.0.CO;2-5</pub-id></citation></ref><ref id="B41"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Chazaud</surname><given-names>C</given-names></name><name><surname>Oulad-Abdelghani</surname><given-names>M</given-names></name><name><surname>Bouillet</surname><given-names>P</given-names></name><name><surname>Decimo</surname><given-names>D</given-names></name><name><surname>Chambon</surname><given-names>P</given-names></name><name><surname>Dolle</surname><given-names>P</given-names></name></person-group><article-title>AP-2.2, a novel gene related to AP-2, is expressed in the forebrain, limbs and face during mouse embryogenesis.</article-title><source>Mech Dev</source><year>1996</year><volume>54</volume><fpage>83</fpage><lpage>94</lpage><pub-id pub-id-type="pmid">8808408</pub-id><pub-id pub-id-type="doi">10.1016/0925-4773(95)00463-7</pub-id></citation></ref><ref id="B42"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Schorle</surname><given-names>H</given-names></name><name><surname>Meier</surname><given-names>P</given-names></name><name><surname>Buchert</surname><given-names>M</given-names></name><name><surname>Jaenisch</surname><given-names>R</given-names></name><name><surname>Mitchell</surname><given-names>PJ</given-names></name></person-group><article-title>Transcription factor AP-2 essential for cranial closure and craniofacial development.</article-title><source>Nature</source><year>1996</year><volume>381</volume><fpage>235</fpage><lpage>238</lpage><pub-id pub-id-type="pmid">8622765</pub-id><pub-id pub-id-type="doi">10.1038/381235a0</pub-id></citation></ref><ref id="B43"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Zhang</surname><given-names>J</given-names></name><name><surname>Hagopian-Donaldson</surname><given-names>S</given-names></name><name><surname>Serbedzija</surname><given-names>G</given-names></name><name><surname>Elsemore</surname><given-names>J</given-names></name><name><surname>Plehn-Dujowich</surname><given-names>D</given-names></name><name><surname>McMahon</surname><given-names>AP</given-names></name><name><surname>Flavell</surname><given-names>RA</given-names></name><name><surname>Williams</surname><given-names>T</given-names></name></person-group><article-title>Neural tube, skeletal and body wall defects in mice lacking transcription factor AP-2.</article-title><source>Nature</source><year>1996</year><volume>381</volume><fpage>238</fpage><lpage>241</lpage><pub-id pub-id-type="pmid">8622766</pub-id><pub-id pub-id-type="doi">10.1038/381238a0</pub-id></citation></ref><ref id="B44"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Moser</surname><given-names>M</given-names></name><name><surname>Dahmen</surname><given-names>S</given-names></name><name><surname>Kluge</surname><given-names>R</given-names></name><name><surname>Grone</surname><given-names>H</given-names></name><name><surname>Dahmen</surname><given-names>J</given-names></name><name><surname>Kunz</surname><given-names>D</given-names></name><name><surname>Schorle</surname><given-names>H</given-names></name><name><surname>Buettner</surname><given-names>R</given-names></name></person-group><article-title>Terminal renal failure in mice lacking transcription factor AP-2 beta.</article-title><source>Lab Invest</source><year>2003</year><volume>83</volume><fpage>571</fpage><lpage>578</lpage><pub-id pub-id-type="pmid">12695560</pub-id></citation></ref><ref id="B45"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Moser</surname><given-names>M</given-names></name><name><surname>Pscherer</surname><given-names>A</given-names></name><name><surname>Roth</surname><given-names>C</given-names></name><name><surname>Becker</surname><given-names>J</given-names></name><name><surname>Mucher</surname><given-names>G</given-names></name><name><surname>Zerres</surname><given-names>K</given-names></name><name><surname>Dixkens</surname><given-names>C</given-names></name><name><surname>Weis</surname><given-names>J</given-names></name><name><surname>Guay-Woodford</surname><given-names>L</given-names></name><name><surname>Buettner</surname><given-names>R</given-names></name><etal></etal></person-group><article-title>Enhanced apoptotic cell death of renal epithelial cells in mice lacking transcription factor AP-2beta.</article-title><source>Genes Dev</source><year>1997</year><volume>11</volume><fpage>1938</fpage><lpage>1948</lpage><pub-id pub-id-type="pmid">9271117</pub-id></citation></ref><ref id="B46"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Auman</surname><given-names>HJ</given-names></name><name><surname>Nottoli</surname><given-names>T</given-names></name><name><surname>Lakiza</surname><given-names>O</given-names></name><name><surname>Winger</surname><given-names>Q</given-names></name><name><surname>Donaldson</surname><given-names>S</given-names></name><name><surname>Williams</surname><given-names>T</given-names></name></person-group><article-title>Transcription factor AP-2gamma is essential in the extraembryonic lineages for early postimplantation development.</article-title><source>Development</source><year>2002</year><volume>129</volume><fpage>2733</fpage><lpage>2747</lpage><pub-id pub-id-type="pmid">12015300</pub-id></citation></ref><ref id="B47"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Werling</surname><given-names>U</given-names></name><name><surname>Schorle</surname><given-names>H</given-names></name></person-group><article-title>Transcription factor gene AP-2 gamma essential for early murine development.</article-title><source>Mol Cell Biol</source><year>2002</year><volume>22</volume><fpage>3149</fpage><lpage>3156</lpage><pub-id pub-id-type="pmid">11940672</pub-id><pub-id pub-id-type="doi">10.1128/MCB.22.9.3149-3156.2002</pub-id></citation></ref><ref id="B48"><citation citation-type="other"><article-title>OMIM - Online Mendelian Inheritance in Man</article-title><ext-link ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=OMIM"/></citation></ref><ref id="B49"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Zhao</surname><given-names>F</given-names></name><name><surname>Weismann</surname><given-names>CG</given-names></name><name><surname>Satoda</surname><given-names>M</given-names></name><name><surname>Pierpont</surname><given-names>ME</given-names></name><name><surname>Sweeney</surname><given-names>E</given-names></name><name><surname>Thompson</surname><given-names>EM</given-names></name><name><surname>Gelb</surname><given-names>BD</given-names></name></person-group><article-title>Novel <italic>TFAP2B</italic> mutations that cause Char syndrome provide a genotype-phenotype correlation.</article-title><source>Am J Hum Genet</source><year>2001</year><volume>69</volume><fpage>695</fpage><lpage>703</lpage><pub-id pub-id-type="pmid">11505339</pub-id><pub-id pub-id-type="doi">10.1086/323410</pub-id></citation></ref><ref id="B50"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Satoda</surname><given-names>M</given-names></name><name><surname>Zhao</surname><given-names>F</given-names></name><name><surname>Diaz</surname><given-names>GA</given-names></name><name><surname>Burn</surname><given-names>J</given-names></name><name><surname>Goodship</surname><given-names>J</given-names></name><name><surname>Davidson</surname><given-names>HR</given-names></name><name><surname>Pierpont</surname><given-names>ME</given-names></name><name><surname>Gelb</surname><given-names>BD</given-names></name></person-group><article-title>Mutations in <italic>TFAP2B</italic> cause Char syndrome, a familial form of patent ductus arteriosus.</article-title><source>Nat Genet</source><year>2000</year><volume>25</volume><fpage>42</fpage><lpage>46</lpage><pub-id pub-id-type="pmid">10802654</pub-id><pub-id pub-id-type="doi">10.1038/75578</pub-id></citation></ref><ref id="B51"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Pfisterer</surname><given-names>P</given-names></name><name><surname>Ehlermann</surname><given-names>J</given-names></name><name><surname>Hegen</surname><given-names>M</given-names></name><name><surname>Schorle</surname><given-names>H</given-names></name></person-group><article-title>A subtractive gene expression screen suggests a role of transcription factor AP-2 alpha in control of proliferation and differentiation.</article-title><source>J Biol Chem</source><year>2002</year><volume>277</volume><fpage>6637</fpage><lpage>6644</lpage><pub-id pub-id-type="pmid">11741941</pub-id><pub-id pub-id-type="doi">10.1074/jbc.M108578200</pub-id></citation></ref><ref id="B52"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Zhang</surname><given-names>J</given-names></name><name><surname>Brewer</surname><given-names>S</given-names></name><name><surname>Huang</surname><given-names>J</given-names></name><name><surname>Williams</surname><given-names>T</given-names></name></person-group><article-title>Overexpression of transcription factor AP-2alpha suppresses mammary gland growth and morphogenesis.</article-title><source>Dev Biol</source><year>2003</year><volume>256</volume><fpage>127</fpage><lpage>145</lpage><pub-id pub-id-type="pmid">12654297</pub-id><pub-id pub-id-type="doi">10.1016/S0012-1606(02)00119-7</pub-id></citation></ref><ref id="B53"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Jager</surname><given-names>R</given-names></name><name><surname>Werling</surname><given-names>U</given-names></name><name><surname>Rimpf</surname><given-names>S</given-names></name><name><surname>Jacob</surname><given-names>A</given-names></name><name><surname>Schorle</surname><given-names>H</given-names></name></person-group><article-title>Transcription factor AP-2gamma stimulates proliferation and apoptosis and impairs differentiation in a transgenic model.</article-title><source>Mol Cancer Res</source><year>2003</year><volume>1</volume><fpage>921</fpage><lpage>929</lpage><pub-id pub-id-type="pmid">14573793</pub-id></citation></ref><ref id="B54"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Pauls</surname><given-names>K</given-names></name><name><surname>Jager</surname><given-names>R</given-names></name><name><surname>Weber</surname><given-names>S</given-names></name><name><surname>Wardelmann</surname><given-names>E</given-names></name><name><surname>Koch</surname><given-names>A</given-names></name><name><surname>Buttner</surname><given-names>R</given-names></name><name><surname>Schorle</surname><given-names>H</given-names></name></person-group><article-title>Transcription factor AP-2gamma, a novel marker of gonocytes and seminomatous germ cell tumors.</article-title><source>Int J Cancer</source><year>2005</year><volume>115</volume><fpage>470</fpage><lpage>477</lpage><pub-id pub-id-type="pmid">15700319</pub-id><pub-id pub-id-type="doi">10.1002/ijc.20913</pub-id></citation></ref><ref id="B55"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Jager</surname><given-names>R</given-names></name><name><surname>Friedrichs</surname><given-names>N</given-names></name><name><surname>Heim</surname><given-names>I</given-names></name><name><surname>Buttner</surname><given-names>R</given-names></name><name><surname>Schorle</surname><given-names>H</given-names></name></person-group><article-title>Dual role of AP-2gamma in ErbB-2-induced mammary tumorigenesis.</article-title><source>Breast Cancer Res Treat</source><year>2005</year><volume>90</volume><fpage>273</fpage><lpage>280</lpage><pub-id pub-id-type="pmid">15830141</pub-id><pub-id pub-id-type="doi">10.1007/s10549-004-4815-x</pub-id></citation></ref><ref id="B56"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Hoei-Hansen</surname><given-names>CE</given-names></name><name><surname>Nielsen</surname><given-names>JE</given-names></name><name><surname>Almstrup</surname><given-names>K</given-names></name><name><surname>Sonne</surname><given-names>SB</given-names></name><name><surname>Graem</surname><given-names>N</given-names></name><name><surname>Skakkebaek</surname><given-names>NE</given-names></name><name><surname>Leffers</surname><given-names>H</given-names></name><name><surname>Meyts</surname><given-names>ER</given-names></name></person-group><article-title>Transcription factor AP-2gamma is a developmentally regulated marker of testicular carcinoma <italic>in situ </italic>and germ cell tumors.</article-title><source>Clin Cancer Res</source><year>2004</year><volume>10</volume><fpage>8521</fpage><lpage>8530</lpage><pub-id pub-id-type="pmid">15623634</pub-id><pub-id pub-id-type="doi">10.1158/1078-0432.CCR-04-1285</pub-id></citation></ref><ref id="B57"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Hurst</surname><given-names>HC</given-names></name></person-group><article-title>Update on HER-2 as a target for cancer therapy: the ERBB2 promoter and its exploitation for cancer treatment.</article-title><source>Breast Cancer Res</source><year>2001</year><volume>3</volume><fpage>395</fpage><lpage>398</lpage><pub-id pub-id-type="pmid">11737892</pub-id><pub-id pub-id-type="doi">10.1186/bcr329</pub-id></citation></ref><ref id="B58"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Beger</surname><given-names>M</given-names></name><name><surname>Butz</surname><given-names>K</given-names></name><name><surname>Denk</surname><given-names>C</given-names></name><name><surname>Williams</surname><given-names>T</given-names></name><name><surname>Hurst</surname><given-names>HC</given-names></name><name><surname>Hoppe-Seyler</surname><given-names>F</given-names></name></person-group><article-title>Expression pattern of AP-2 transcription factors in cervical cancer cells and analysis of their influence on human papillomavirus oncogene transcription.</article-title><source>J Mol Med</source><year>2001</year><volume>79</volume><fpage>314</fpage><lpage>320</lpage><pub-id pub-id-type="pmid">11485026</pub-id><pub-id pub-id-type="doi">10.1007/s001090100211</pub-id></citation></ref><ref id="B59"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Turner</surname><given-names>BC</given-names></name><name><surname>Zhang</surname><given-names>J</given-names></name><name><surname>Gumbs</surname><given-names>AA</given-names></name><name><surname>Maher</surname><given-names>MG</given-names></name><name><surname>Kaplan</surname><given-names>L</given-names></name><name><surname>Carter</surname><given-names>D</given-names></name><name><surname>Glazer</surname><given-names>PM</given-names></name><name><surname>Hurst</surname><given-names>HC</given-names></name><name><surname>Haffty</surname><given-names>BG</given-names></name><name><surname>Williams</surname><given-names>T</given-names></name></person-group><article-title>Expression of AP-2 transcription factors in human breast cancer correlates with the regulation of multiple growth factor signalling pathways.</article-title><source>Cancer Res</source><year>1998</year><volume>58</volume><fpage>5466</fpage><lpage>5472</lpage><pub-id pub-id-type="pmid">9850080</pub-id></citation></ref><ref id="B60"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Bosher</surname><given-names>JM</given-names></name><name><surname>Totty</surname><given-names>NF</given-names></name><name><surname>Hsuan</surname><given-names>JJ</given-names></name><name><surname>Williams</surname><given-names>T</given-names></name><name><surname>Hurst</surname><given-names>HC</given-names></name></person-group><article-title>A family of AP-2 proteins regulates c-erbB-2 expression in mammary carcinoma.</article-title><source>Oncogene</source><year>1996</year><volume>13</volume><fpage>1701</fpage><lpage>1707</lpage><pub-id pub-id-type="pmid">8895516</pub-id></citation></ref><ref id="B61"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Nelson</surname><given-names>DK</given-names></name><name><surname>Williams</surname><given-names>T</given-names></name></person-group><article-title>Frontonasal process-specific disruption of AP-2alpha results in postnatal midfacial hypoplasia, vascular anomalies, and nasal cavity defects.</article-title><source>Dev Biol</source><year>2004</year><volume>267</volume><fpage>72</fpage><lpage>92</lpage><pub-id pub-id-type="pmid">14975718</pub-id><pub-id pub-id-type="doi">10.1016/j.ydbio.2003.10.033</pub-id></citation></ref><ref id="B62"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Brewer</surname><given-names>S</given-names></name><name><surname>Feng</surname><given-names>W</given-names></name><name><surname>Huang</surname><given-names>J</given-names></name><name><surname>Sullivan</surname><given-names>S</given-names></name><name><surname>Williams</surname><given-names>T</given-names></name></person-group><article-title>Wnt1-Cre-mediated deletion of AP-2alpha causes multiple neural crest-related defects.</article-title><source>Dev Biol</source><year>2004</year><volume>267</volume><fpage>135</fpage><lpage>152</lpage><pub-id pub-id-type="pmid">14975722</pub-id><pub-id pub-id-type="doi">10.1016/j.ydbio.2003.10.039</pub-id></citation></ref><ref id="B63"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Werling</surname><given-names>U</given-names></name><name><surname>Schorle</surname><given-names>H</given-names></name></person-group><article-title>Conditional inactivation of transcription factor AP-2gamma by using the Cre/loxP recombination system.</article-title><source>Genesis</source><year>2002</year><volume>32</volume><fpage>127</fpage><lpage>129</lpage><pub-id pub-id-type="pmid">11857798</pub-id><pub-id pub-id-type="doi">10.1002/gene.10057</pub-id></citation></ref><ref id="B64"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Luo</surname><given-names>T</given-names></name><name><surname>Zhang</surname><given-names>Y</given-names></name><name><surname>Khadka</surname><given-names>D</given-names></name><name><surname>Rangarajan</surname><given-names>J</given-names></name><name><surname>Cho</surname><given-names>KW</given-names></name><name><surname>Sargent</surname><given-names>TD</given-names></name></person-group><article-title>Regulatory targets for transcription factor AP2 in <italic>Xenopus </italic>embryos.</article-title><source>Dev Growth Differ</source><year>2005</year><volume>47</volume><fpage>403</fpage><lpage>413</lpage><pub-id pub-id-type="pmid">16109038</pub-id><pub-id pub-id-type="doi">10.1111/j.1440-169X.2005.00809.x</pub-id></citation></ref><ref id="B65"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Friedrichs</surname><given-names>N</given-names></name><name><surname>Jager</surname><given-names>R</given-names></name><name><surname>Paggen</surname><given-names>E</given-names></name><name><surname>Rudlowski</surname><given-names>C</given-names></name><name><surname>Merkelbach-Bruse</surname><given-names>S</given-names></name><name><surname>Schorle</surname><given-names>H</given-names></name><name><surname>Buettner</surname><given-names>R</given-names></name></person-group><article-title>Distinct spatial expression patterns of AP-2alpha and AP-2gamma in non-neoplastic human breast and breast cancer.</article-title><source>Mod Pathol</source><year>2005</year><volume>18</volume><fpage>431</fpage><lpage>438</lpage><pub-id pub-id-type="pmid">15467710</pub-id><pub-id pub-id-type="doi">10.1038/modpathol.3800292</pub-id></citation></ref><ref id="B66"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Hoei-Hansen</surname><given-names>CE</given-names></name><name><surname>Nielsen</surname><given-names>JE</given-names></name><name><surname>Almstrup</surname><given-names>K</given-names></name><name><surname>Hansen</surname><given-names>MA</given-names></name><name><surname>Skakkebaek</surname><given-names>NE</given-names></name><name><surname>Rajpert-DeMeyts</surname><given-names>E</given-names></name><name><surname>Leffers</surname><given-names>H</given-names></name></person-group><article-title>Identification of genes differentially expressed in testes containing carcinoma <italic>in situ</italic>.</article-title><source>Mol Hum Reprod</source><year>2004</year><volume>10</volume><fpage>423</fpage><lpage>431</lpage><pub-id pub-id-type="pmid">15123780</pub-id><pub-id pub-id-type="doi">10.1093/molehr/gah059</pub-id></citation></ref><ref id="B67"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Kumar</surname><given-names>S</given-names></name><name><surname>Tamura</surname><given-names>K</given-names></name><name><surname>Nei</surname><given-names>M</given-names></name></person-group><article-title>MEGA3: Integrated software for Molecular Evolutionary Genetics Analysis and sequence alignment.</article-title><source>Brief Bioinform</source><year>2004</year><volume>5</volume><fpage>150</fpage><lpage>163</lpage><pub-id pub-id-type="pmid">15260895</pub-id><pub-id pub-id-type="doi">10.1186/1471-2105-5-150</pub-id></citation></ref><ref id="B68"><citation citation-type="other"><article-title>Swiss-Prot</article-title><ext-link ext-link-type="uri" xlink:href="http://us.expasy.org/sprot/"/></citation></ref><ref id="B69"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Braganca</surname><given-names>J</given-names></name><name><surname>Eloranta</surname><given-names>JJ</given-names></name><name><surname>Bamforth</surname><given-names>SD</given-names></name><name><surname>Ibbitt</surname><given-names>JC</given-names></name><name><surname>Hurst</surname><given-names>HC</given-names></name><name><surname>Bhattacharya</surname><given-names>S</given-names></name></person-group><article-title>Physical and functional interactions among AP-2 transcription factors, p300/CREB-binding protein, and CITED2.</article-title><source>J Biol Chem</source><year>2003</year><volume>278</volume><fpage>16021</fpage><lpage>16029</lpage><pub-id pub-id-type="pmid">12586840</pub-id><pub-id pub-id-type="doi">10.1074/jbc.M208144200</pub-id></citation></ref><ref id="B70"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Braganca</surname><given-names>J</given-names></name><name><surname>Swingler</surname><given-names>T</given-names></name><name><surname>Marques</surname><given-names>FI</given-names></name><name><surname>Jones</surname><given-names>T</given-names></name><name><surname>Eloranta</surname><given-names>JJ</given-names></name><name><surname>Hurst</surname><given-names>HC</given-names></name><name><surname>Shioda</surname><given-names>T</given-names></name><name><surname>Bhattacharya</surname><given-names>S</given-names></name></person-group><article-title>Human CREB-binding protein/p300-interacting transactivator with ED-rich tail (CITED) 4, a new member of the CITED family, functions as a co-activator for transcription factor AP-2.</article-title><source>J Biol Chem</source><year>2002</year><volume>277</volume><fpage>8559</fpage><lpage>8565</lpage><pub-id pub-id-type="pmid">11744733</pub-id><pub-id pub-id-type="doi">10.1074/jbc.M110850200</pub-id></citation></ref><ref id="B71"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Wu</surname><given-names>F</given-names></name><name><surname>Lee</surname><given-names>AS</given-names></name></person-group><article-title>CDP and AP-2 mediated repression mechanism of the replication-dependent hamster histone H3.2 promoter.</article-title><source>J Cell Biochem</source><year>2002</year><volume>84</volume><fpage>699</fpage><lpage>707</lpage><pub-id pub-id-type="pmid">11835395</pub-id><pub-id pub-id-type="doi">10.1002/jcb.10094</pub-id></citation></ref><ref id="B72"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Campillos</surname><given-names>M</given-names></name><name><surname>Garcia</surname><given-names>MA</given-names></name><name><surname>Valdivieso</surname><given-names>F</given-names></name><name><surname>Vazquez</surname><given-names>J</given-names></name></person-group><article-title>Transcriptional activation by AP-2alpha is modulated by the oncogene DEK.</article-title><source>Nucleic Acids Res</source><year>2003</year><volume>31</volume><fpage>1571</fpage><lpage>1575</lpage><pub-id pub-id-type="pmid">12595566</pub-id><pub-id pub-id-type="doi">10.1093/nar/gkg247</pub-id></citation></ref><ref id="B73"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Somasundaram</surname><given-names>K</given-names></name><name><surname>Jayaraman</surname><given-names>G</given-names></name><name><surname>Williams</surname><given-names>T</given-names></name><name><surname>Moran</surname><given-names>E</given-names></name><name><surname>Frisch</surname><given-names>S</given-names></name><name><surname>Thimmapaya</surname><given-names>B</given-names></name></person-group><article-title>Repression of a matrix metalloprotease gene by E1A correlates with its ability to bind to cell type-specific transcription factor AP-2.</article-title><source>Proc Natl Acad Sci USA</source><year>1996</year><volume>93</volume><fpage>3088</fpage><lpage>3093</lpage><pub-id pub-id-type="pmid">8610173</pub-id><pub-id pub-id-type="doi">10.1073/pnas.93.7.3088</pub-id></citation></ref><ref id="B74"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Kannan</surname><given-names>P</given-names></name><name><surname>Yu</surname><given-names>Y</given-names></name><name><surname>Wankhade</surname><given-names>S</given-names></name><name><surname>Tainsky</surname><given-names>MA</given-names></name></person-group><article-title>PolyADP-ribose polymerase is a coactivator for AP-2-mediated transcriptional activation.</article-title><source>Nucleic Acids Res</source><year>1999</year><volume>27</volume><fpage>866</fpage><lpage>874</lpage><pub-id pub-id-type="pmid">9889285</pub-id><pub-id pub-id-type="doi">10.1093/nar/27.3.866</pub-id></citation></ref><ref id="B75"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Sivak</surname><given-names>JM</given-names></name><name><surname>West-Mays</surname><given-names>JA</given-names></name><name><surname>Yee</surname><given-names>A</given-names></name><name><surname>Williams</surname><given-names>T</given-names></name><name><surname>Fini</surname><given-names>ME</given-names></name></person-group><article-title>Transcription factors Pax6 and AP-2alpha interact to coordinate corneal epithelial repair by controlling expression of matrix metalloproteinase gelatinase B.</article-title><source>Mol Cell Biol</source><year>2004</year><volume>24</volume><fpage>245</fpage><lpage>257</lpage><pub-id pub-id-type="pmid">14673159</pub-id><pub-id pub-id-type="doi">10.1128/MCB.24.1.245-257.2004</pub-id></citation></ref><ref id="B76"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>McPherson</surname><given-names>LA</given-names></name><name><surname>Loktev</surname><given-names>AV</given-names></name><name><surname>Weigel</surname><given-names>RJ</given-names></name></person-group><article-title>Tumor suppressor activity of AP2alpha mediated through a direct interaction with p53.</article-title><source>J Biol Chem</source><year>2002</year><volume>277</volume><fpage>45028</fpage><lpage>45033</lpage><pub-id pub-id-type="pmid">12226108</pub-id><pub-id pub-id-type="doi">10.1074/jbc.M208924200</pub-id></citation></ref><ref id="B77"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Wu</surname><given-names>F</given-names></name><name><surname>Lee</surname><given-names>AS</given-names></name></person-group><article-title>Identification of AP-2 as an interactive target of Rb and a regulator of the G1/S control element of the hamster histone H3.2 promoter.</article-title><source>Nucleic Acids Res</source><year>1998</year><volume>26</volume><fpage>4837</fpage><lpage>4845</lpage><pub-id pub-id-type="pmid">9776742</pub-id><pub-id pub-id-type="doi">10.1093/nar/26.21.4837</pub-id></citation></ref><ref id="B78"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Batsche</surname><given-names>E</given-names></name><name><surname>Muchardt</surname><given-names>C</given-names></name><name><surname>Behrens</surname><given-names>J</given-names></name><name><surname>Hurst</surname><given-names>HC</given-names></name><name><surname>Cremisi</surname><given-names>C</given-names></name></person-group><article-title>RB and c-Myc activate expression of the E-cadherin gene in epithelial cells through interaction with transcription factor AP-2.</article-title><source>Mol Cell Biol</source><year>1998</year><volume>18</volume><fpage>3647</fpage><lpage>3658</lpage><pub-id pub-id-type="pmid">9632747</pub-id></citation></ref><ref id="B79"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Pena</surname><given-names>P</given-names></name><name><surname>Reutens</surname><given-names>AT</given-names></name><name><surname>Albanese</surname><given-names>C</given-names></name><name><surname>D'Amico</surname><given-names>M</given-names></name><name><surname>Watanabe</surname><given-names>G</given-names></name><name><surname>Donner</surname><given-names>A</given-names></name><name><surname>Shu</surname><given-names>IW</given-names></name><name><surname>Williams</surname><given-names>T</given-names></name><name><surname>Pestell</surname><given-names>RG</given-names></name></person-group><article-title>Activator protein-2 mediates transcriptional activation of the CYP11A1 gene by interaction with Sp1 rather than binding to DNA.</article-title><source>Mol Endocrinol</source><year>1999</year><volume>13</volume><fpage>1402</fpage><lpage>1416</lpage><pub-id pub-id-type="pmid">10446912</pub-id><pub-id pub-id-type="doi">10.1210/me.13.8.1402</pub-id></citation></ref><ref id="B80"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Eloranta</surname><given-names>JJ</given-names></name><name><surname>Hurst</surname><given-names>HC</given-names></name></person-group><article-title>Transcription factor AP-2 interacts with the SUMO-conjugating enzyme UBC9 and is sumolated <italic>in vivo</italic>.</article-title><source>J Biol Chem</source><year>2002</year><volume>277</volume><fpage>30798</fpage><lpage>30804</lpage><pub-id pub-id-type="pmid">12072434</pub-id><pub-id pub-id-type="doi">10.1074/jbc.M202780200</pub-id></citation></ref><ref id="B81"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Mertens</surname><given-names>PR</given-names></name><name><surname>Alfonso-Jaume</surname><given-names>MA</given-names></name><name><surname>Steinmann</surname><given-names>K</given-names></name><name><surname>Lovett</surname><given-names>DH</given-names></name></person-group><article-title>A synergistic interaction of transcription factors AP2 and YB-1 regulates gelatinase A enhancer-dependent transcription.</article-title><source>J Biol Chem</source><year>1998</year><volume>273</volume><fpage>32957</fpage><lpage>32965</lpage><pub-id pub-id-type="pmid">9830047</pub-id><pub-id pub-id-type="doi">10.1074/jbc.273.49.32957</pub-id></citation></ref><ref id="B82"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Wu</surname><given-names>F</given-names></name><name><surname>Lee</surname><given-names>AS</given-names></name></person-group><article-title>YY1 as a regulator of replication-dependent hamster histone H3.2 promoter and an interactive partner of AP-2.</article-title><source>J Biol Chem</source><year>2001</year><volume>276</volume><fpage>28</fpage><lpage>34</lpage><pub-id pub-id-type="pmid">11018030</pub-id><pub-id pub-id-type="doi">10.1074/jbc.M006074200</pub-id></citation></ref></ref-list><sec sec-type="display-objects"><title>Figures and Tables</title><fig position="float" id="F1"><label>Figure 1</label><caption><p>Phylogenetic tree of the AP-2 family. Amino-acid sequence alignments were performed using ClustalW implemented in Sequence Data Explorer of the MEGA3 software [67]. The phylogenetic tree was created using the neighbor-joining method (gaps setting: pairwise deletion; distance method: number of differences). Numbers at selected nodes indicate the percentage frequencies of branch association on the basis of 1,000 bootstrap repetitions. The scale bar indicates the number of residue changes. Asterisks indicate predicted proteins; brackets denote subfamilies in vertebrates. Species: <italic>Caenorhabditis elegans </italic>(nematode); <italic>Ciona intestinalis </italic>(sea squirt); <italic>Drosophila melanogaster </italic>(fruit fly); <italic>Danio rerio </italic>(zebrafish); <italic>Gallus gallus </italic>(chicken); <italic>Homo sapiens </italic>(human); <italic>Mus musculus </italic>(mouse); <italic>Pan troglodytes </italic>(chimpanzee); <italic>Rattus norvegicus </italic>(rat); <italic>Xenopus laevis </italic>and <italic>Xenopus tropicalis </italic>(frog).</p></caption><graphic xlink:href="gb-2005-6-13-246-1"/></fig><fig position="float" id="F2"><label>Figure 2</label><caption><p>A schematic representation of the protein structure of an AP-2&#x003b1; dimer, showing the proline- and glutamine (P/Q)-rich transactivation domain (89 amino acids, red), the PY motif within this domain (5 amino acids, green), the basic domain (20 amino acids, yellow) and the helix-span-helix motif (131 amino acids, blue). The helix-span-helix motif is responsible for dimerization of the proteins and mediates DNA binding together with the basic domain. Modified from SwissProt, ID: <ext-link ext-link-type="sprot" xlink:href="P34056">P34056</ext-link> [68].</p></caption><graphic xlink:href="gb-2005-6-13-246-2"/></fig><table-wrap position="float" id="T1"><label>Table 1</label><caption><p>Chromosomal locations of <italic>AP-2 </italic>genes from selected species</p></caption><table frame="hsides" rules="groups"><thead><tr><td></td><td align="left"><italic>AP-2&#x003b1;</italic></td><td align="left"><italic>AP-2&#x003b2;</italic></td><td align="left"><italic>AP-2&#x003b3;</italic></td><td align="left"><italic>AP-2&#x003b4;</italic></td><td align="left"><italic>AP-2&#x003b5;</italic></td><td align="left">Other <italic>AP-2</italic> genes*</td></tr></thead><tbody><tr><td align="left"><italic>H. sapiens</italic></td><td align="left">6p24</td><td align="left">6p12</td><td align="left">20q13.2</td><td align="left">6p12.1</td><td align="left">1p34.3</td><td></td></tr><tr><td align="left"><italic>P. troglodytes</italic></td><td align="left">6p22.3</td><td align="left">6p12</td><td align="left">21</td><td align="left">-</td><td align="left">-</td><td></td></tr><tr><td align="left"><italic>M. musculus</italic></td><td align="left">13 A5-B1</td><td align="left">1 A2-A4</td><td align="left">2 H3-H4</td><td align="left">1 A3</td><td align="left">4 D2.2</td><td></td></tr><tr><td align="left"><italic>R. norvegicus</italic></td><td align="left">17p12</td><td align="left">9q13</td><td align="left">3q42</td><td align="left">9q13</td><td align="left">5q36</td><td></td></tr><tr><td align="left"><italic>G. gallus</italic></td><td align="left">2 3</td><td align="left">-</td><td align="left">3</td><td align="left">-</td><td></td><td></td></tr><tr><td align="left"><italic>X. tropicalis</italic></td><td align="left">scaffold_278</td><td align="left">-</td><td align="left">-</td><td align="left">-</td><td align="left">-</td><td></td></tr><tr><td align="left"><italic>D. rerio</italic></td><td align="left">24</td><td align="left">20</td><td align="left">-</td><td align="left">-</td><td align="left">-</td><td></td></tr><tr><td align="left"><italic>C. elegans</italic></td><td></td><td></td><td></td><td></td><td></td><td align="left">II</td></tr><tr><td align="left"><italic>D. melanogaster</italic></td><td></td><td></td><td></td><td></td><td></td><td align="left">3L</td></tr></tbody></table><table-wrap-foot><p>*The <italic>AP-2</italic> genes of <italic>C. elegans </italic>and <italic>D. melanogaster </italic>are not orthologous to any of the five mammalian genes. Data taken from the database entries for the accession numbers given in Table 2. No information on mapping is available for the <italic>C. intestinalis AP</italic>-2 gene.</p></table-wrap-foot></table-wrap><table-wrap position="float" id="T2"><label>Table 2</label><caption><p>Accession numbers for AP-2 proteins from selected species</p></caption><table frame="hsides" rules="groups"><thead><tr><td></td><td align="left">AP-2&#x003b1;</td><td align="left">AP-2&#x003b2;</td><td align="left">AP-2&#x003b3;</td><td align="left">AP-2&#x003b4;</td><td align="left">AP-2&#x003b5;</td><td align="left">Other AP-2 proteins*</td></tr></thead><tbody><tr><td align="left"><italic>H. sapiens</italic></td><td align="left">NP_003211</td><td align="left">NP_003212</td><td align="left">NP_003213</td><td align="left">NP_758438</td><td align="left">NP_848643</td><td></td></tr><tr><td align="left"><italic>P. troglodytes</italic></td><td align="left">-</td><td align="left">XP_518532</td><td align="left">XP_526337</td><td align="left">-</td><td align="left">-</td><td></td></tr><tr><td align="left"><italic>M. musculus</italic></td><td align="left">NP_035677</td><td align="left">NP_033360</td><td align="left">NP_033361</td><td align="left">NP_694794</td><td align="left">NP_945198</td><td></td></tr><tr><td align="left"><italic>R. norvegicus</italic></td><td align="left">XP_225238</td><td align="left">XP_217356</td><td align="left">NP_958823</td><td align="left">XP_236975</td><td align="left">XP_233526</td><td></td></tr><tr><td align="left"><italic>G. gallus</italic></td><td align="left">NP_990425</td><td align="left">NP_990226</td><td align="left">-</td><td align="left">XP_426224</td><td align="left">-</td><td></td></tr><tr><td align="left"><italic>X. tropicalis</italic></td><td align="left">AAD53289</td><td align="left">-</td><td align="left">-</td><td align="left">-</td><td align="left">-</td><td></td></tr><tr><td align="left"><italic>X. laevis</italic></td><td align="left">AAA49972</td><td align="left">-</td><td align="left">-</td><td align="left">-</td><td align="left">-</td><td></td></tr><tr><td align="left"><italic>D. rerio</italic></td><td align="left">NP_789829</td><td align="left">NP_001019836</td><td align="left">-</td><td align="left">-</td><td align="left">-</td><td></td></tr><tr><td align="left"><italic>C. elegans</italic></td><td></td><td></td><td></td><td></td><td></td><td align="left">NP_4951819</td></tr><tr><td align="left"><italic>D. melanogaster</italic></td><td></td><td></td><td></td><td></td><td></td><td align="left">NP_730664</td></tr><tr><td align="left"><italic>C. intestinalis</italic></td><td></td><td></td><td></td><td></td><td></td><td align="left">BAE06307 and BAE06308</td></tr></tbody></table><table-wrap-foot><p>*The <italic>AP-2</italic> genes of <italic>C. elegans</italic>, <italic>D. melanogaster </italic>and <italic>C. intestinalis </italic>are not orthologous to any of the five mammalian genes.</p></table-wrap-foot></table-wrap><table-wrap position="float" id="T3"><label>Table 3</label><caption><p>Proteins that physically interact with AP-2 transcription factors</p></caption><table frame="hsides" rules="groups"><thead><tr><td align="left">Protein</td><td align="left">Description</td><td align="left">Domain of AP-2 proteins that interacts*</td><td align="left">Function of interaction</td><td align="left">Reference</td></tr></thead><tbody><tr><td align="left">APC</td><td align="left">Adenomatous polyposis coli tumor suppressor</td><td align="left">Basic region</td><td align="left">Inhibition of &#x003b2;-catenin/TCF/LEF-dependent transcription</td><td align="left">[16]</td></tr><tr><td align="left">CITED2</td><td align="left">Coactivator</td><td align="left">DD</td><td align="left">Transcriptional activation</td><td align="left">[69]</td></tr><tr><td align="left">CITED4</td><td align="left">Coactivator</td><td align="left">n.d.</td><td align="left">Transcriptional activation</td><td align="left">[70]</td></tr><tr><td align="left">CDP</td><td align="left">CCAAT displacement protein</td><td align="left">DBD, DD</td><td align="left">Repression of the hamster histone H3.2 promoter</td><td align="left">[71]</td></tr><tr><td align="left">DEK</td><td align="left">Oncoprotein, chromatin remodeling</td><td align="left">n.d.</td><td align="left">Transcriptional activation</td><td align="left">[72]</td></tr><tr><td align="left">E1A</td><td align="left">Transforming protein of adenovirus</td><td align="left">DBD, DD</td><td align="left">Repression of AP-2 target genes</td><td align="left">[73]</td></tr><tr><td align="left"><italic>c</italic>-Myc</td><td align="left">Oncoprotein</td><td align="left">Carboxyl terminus</td><td align="left">Impairment of Myc/Max DNA-binding and transactivation</td><td align="left">[14]</td></tr><tr><td align="left">PARP</td><td align="left">PolyADP-ribose polymerase</td><td align="left">Carboxyl terminus</td><td align="left">Transcriptional activation</td><td align="left">[74]</td></tr><tr><td align="left">PAX-6</td><td align="left">Transcription factor</td><td align="left">n.d.</td><td align="left">Stimulation of gelatinase B activation</td><td align="left">[75]</td></tr><tr><td align="left">PC4</td><td align="left">Coactivator</td><td></td><td align="left">Transcriptional activation</td><td align="left">[24]</td></tr><tr><td align="left">P300/CBP</td><td align="left">Coactivator</td><td align="left">Amino terminus</td><td align="left">Transcriptional activation</td><td align="left">[69]</td></tr><tr><td align="left">p53</td><td align="left">Tumor suppressor</td><td align="left">n.d.</td><td align="left">Augmentation of p53-dependent transcription</td><td align="left">[76]</td></tr><tr><td align="left">RAP74</td><td align="left">Subunit of transcription factor TFIIF</td><td align="left">Central region containing DBD</td><td align="left">Unknown</td><td align="left">[74]</td></tr><tr><td align="left">Rb</td><td align="left">Retinoblastoma tumor suppressor</td><td align="left">Amino terminus<sup>&#x02020;</sup></td><td align="left">Repression of the hamster histone H3.2 promoter; transcriptional activation of the <italic>E-cadherin </italic>gene</td><td align="left">[77,78]</td></tr><tr><td align="left">SP1</td><td align="left">Transcription factor</td><td align="left">Basic region</td><td align="left">Transcriptional activation of the ovine <italic>CYP11A</italic>1 gene</td><td align="left">[79]</td></tr><tr><td align="left">SV40T</td><td align="left">Transforming protein of SV40 virus</td><td align="left">n.d.</td><td align="left">Blocks DNA binding of AP-2 protein</td><td align="left">[12]</td></tr><tr><td align="left">UBC9</td><td align="left">E2-conjugating enzyme</td><td align="left">DBD, DD</td><td align="left">Sumoylation</td><td align="left">[80]</td></tr><tr><td align="left">WWOX</td><td align="left">Tumor suppressor</td><td align="left">Amino terminus PY motif</td><td align="left">Cytoplasmic localization PPPY motif</td><td align="left">[17]</td></tr><tr><td align="left">YB-1</td><td align="left">Transcription factor</td><td align="left">n.d.</td><td align="left">Stimulation of gelatinase A transcription</td><td align="left">[81]</td></tr><tr><td align="left">YY1</td><td align="left">Transcription factor</td><td align="left">DBD, DD</td><td align="left">Stimulation of the hamster histone H3.2 promoter</td><td align="left">[82]</td></tr></tbody></table><table-wrap-foot><p>*Abbreviations: DBD, DNA-binding domain; DD, dimerization domain; n.d., not determined. <sup>&#x02020;</sup>It is currently not entirely clear whether Rb binds AP-2 only via the amino terminus [78], or whether the DNA-binding domain is also necessary [77].</p></table-wrap-foot></table-wrap></sec></back></article> 